Treatment of Hypersomnia

Erik K St Louis, C. Stephenson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Central nervous system (CNS) hypersomnia disorders such as narcolepsy and idiopathic hypersomnia significantly impair quality of life and lead to safety risks in driving and occupational abilities. Effectively and tolerably counteracting hypersomnia symptoms is thus a critical public health mandate. Pharmacological treatment with stimulants remains the mainstay of care for CNS hypersomnia patients. Traditional sympathomimetic stimulants including methylphenidate and amphetamines remain the most effective and commonly used options for most patients, although the advent of the nonsympathomimetic stimulant agents modafinil and armodafinil has provided effective yet safer and more tolerable treatment options for many narcolepsy patients. Anticataplectic treatments for narcolepsy patients include tricyclic and selective serotonin reuptake inhibitor antidepressants and sodium oxybate, the sodium salt of γ-hydroxybutyrate. Important adjunctive treatments for hypersomnia include caffeine and several nonpharmacologic measures such as prescribed napping, sleep hygiene education, relaxation training, cognitive behavioral therapy, and bright light therapy. Effective and tolerable treatment strategies for hypersomnia patients first requires an accurate diagnosis of the underlying cause or causes, expert knowledge of the complex clinical pharmacology of available stimulant and anticataplectic treatments, and familiarity with nonpharmacologic options with tailoring of the most appropriate combination of treatments to the individual patient.

Original languageEnglish (US)
Title of host publicationEncyclopedia of Sleep
PublisherElsevier Inc.
Pages513-519
Number of pages7
ISBN (Electronic)9780123786111
ISBN (Print)9780123786104
DOIs
StatePublished - Jan 1 2013

Fingerprint

Disorders of Excessive Somnolence
Narcolepsy
Therapeutics
Idiopathic Hypersomnolence
Sodium Oxybate
Hydroxybutyrates
Amphetamines
Sympathomimetics
Methylphenidate
Aptitude
Phototherapy
Clinical Pharmacology
Central Nervous System Diseases
Serotonin Uptake Inhibitors
Cognitive Therapy
Caffeine
Antidepressive Agents
Central Nervous System
Public Health
Salts

Keywords

  • Adverse effects
  • Amphetamines
  • Caffeine
  • Cataplexy
  • Cognitive behavioral therapy
  • Fluoxetine
  • Hypersomnia
  • Light therapy
  • Methylphenidate
  • Modafinil
  • Narcolepsy
  • Pharmacology
  • Stimulants
  • Therapy
  • Venlafaxine
  • γ-Hydroxybutyrate

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

St Louis, E. K., & Stephenson, C. (2013). Treatment of Hypersomnia. In Encyclopedia of Sleep (pp. 513-519). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-378610-4.00245-X

Treatment of Hypersomnia. / St Louis, Erik K; Stephenson, C.

Encyclopedia of Sleep. Elsevier Inc., 2013. p. 513-519.

Research output: Chapter in Book/Report/Conference proceedingChapter

St Louis, EK & Stephenson, C 2013, Treatment of Hypersomnia. in Encyclopedia of Sleep. Elsevier Inc., pp. 513-519. https://doi.org/10.1016/B978-0-12-378610-4.00245-X
St Louis EK, Stephenson C. Treatment of Hypersomnia. In Encyclopedia of Sleep. Elsevier Inc. 2013. p. 513-519 https://doi.org/10.1016/B978-0-12-378610-4.00245-X
St Louis, Erik K ; Stephenson, C. / Treatment of Hypersomnia. Encyclopedia of Sleep. Elsevier Inc., 2013. pp. 513-519
@inbook{5127fb2b8bed4a78bb379c6e69b43b74,
title = "Treatment of Hypersomnia",
abstract = "Central nervous system (CNS) hypersomnia disorders such as narcolepsy and idiopathic hypersomnia significantly impair quality of life and lead to safety risks in driving and occupational abilities. Effectively and tolerably counteracting hypersomnia symptoms is thus a critical public health mandate. Pharmacological treatment with stimulants remains the mainstay of care for CNS hypersomnia patients. Traditional sympathomimetic stimulants including methylphenidate and amphetamines remain the most effective and commonly used options for most patients, although the advent of the nonsympathomimetic stimulant agents modafinil and armodafinil has provided effective yet safer and more tolerable treatment options for many narcolepsy patients. Anticataplectic treatments for narcolepsy patients include tricyclic and selective serotonin reuptake inhibitor antidepressants and sodium oxybate, the sodium salt of γ-hydroxybutyrate. Important adjunctive treatments for hypersomnia include caffeine and several nonpharmacologic measures such as prescribed napping, sleep hygiene education, relaxation training, cognitive behavioral therapy, and bright light therapy. Effective and tolerable treatment strategies for hypersomnia patients first requires an accurate diagnosis of the underlying cause or causes, expert knowledge of the complex clinical pharmacology of available stimulant and anticataplectic treatments, and familiarity with nonpharmacologic options with tailoring of the most appropriate combination of treatments to the individual patient.",
keywords = "Adverse effects, Amphetamines, Caffeine, Cataplexy, Cognitive behavioral therapy, Fluoxetine, Hypersomnia, Light therapy, Methylphenidate, Modafinil, Narcolepsy, Pharmacology, Stimulants, Therapy, Venlafaxine, γ-Hydroxybutyrate",
author = "{St Louis}, {Erik K} and C. Stephenson",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-378610-4.00245-X",
language = "English (US)",
isbn = "9780123786104",
pages = "513--519",
booktitle = "Encyclopedia of Sleep",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Treatment of Hypersomnia

AU - St Louis, Erik K

AU - Stephenson, C.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Central nervous system (CNS) hypersomnia disorders such as narcolepsy and idiopathic hypersomnia significantly impair quality of life and lead to safety risks in driving and occupational abilities. Effectively and tolerably counteracting hypersomnia symptoms is thus a critical public health mandate. Pharmacological treatment with stimulants remains the mainstay of care for CNS hypersomnia patients. Traditional sympathomimetic stimulants including methylphenidate and amphetamines remain the most effective and commonly used options for most patients, although the advent of the nonsympathomimetic stimulant agents modafinil and armodafinil has provided effective yet safer and more tolerable treatment options for many narcolepsy patients. Anticataplectic treatments for narcolepsy patients include tricyclic and selective serotonin reuptake inhibitor antidepressants and sodium oxybate, the sodium salt of γ-hydroxybutyrate. Important adjunctive treatments for hypersomnia include caffeine and several nonpharmacologic measures such as prescribed napping, sleep hygiene education, relaxation training, cognitive behavioral therapy, and bright light therapy. Effective and tolerable treatment strategies for hypersomnia patients first requires an accurate diagnosis of the underlying cause or causes, expert knowledge of the complex clinical pharmacology of available stimulant and anticataplectic treatments, and familiarity with nonpharmacologic options with tailoring of the most appropriate combination of treatments to the individual patient.

AB - Central nervous system (CNS) hypersomnia disorders such as narcolepsy and idiopathic hypersomnia significantly impair quality of life and lead to safety risks in driving and occupational abilities. Effectively and tolerably counteracting hypersomnia symptoms is thus a critical public health mandate. Pharmacological treatment with stimulants remains the mainstay of care for CNS hypersomnia patients. Traditional sympathomimetic stimulants including methylphenidate and amphetamines remain the most effective and commonly used options for most patients, although the advent of the nonsympathomimetic stimulant agents modafinil and armodafinil has provided effective yet safer and more tolerable treatment options for many narcolepsy patients. Anticataplectic treatments for narcolepsy patients include tricyclic and selective serotonin reuptake inhibitor antidepressants and sodium oxybate, the sodium salt of γ-hydroxybutyrate. Important adjunctive treatments for hypersomnia include caffeine and several nonpharmacologic measures such as prescribed napping, sleep hygiene education, relaxation training, cognitive behavioral therapy, and bright light therapy. Effective and tolerable treatment strategies for hypersomnia patients first requires an accurate diagnosis of the underlying cause or causes, expert knowledge of the complex clinical pharmacology of available stimulant and anticataplectic treatments, and familiarity with nonpharmacologic options with tailoring of the most appropriate combination of treatments to the individual patient.

KW - Adverse effects

KW - Amphetamines

KW - Caffeine

KW - Cataplexy

KW - Cognitive behavioral therapy

KW - Fluoxetine

KW - Hypersomnia

KW - Light therapy

KW - Methylphenidate

KW - Modafinil

KW - Narcolepsy

KW - Pharmacology

KW - Stimulants

KW - Therapy

KW - Venlafaxine

KW - γ-Hydroxybutyrate

UR - http://www.scopus.com/inward/record.url?scp=85070020731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070020731&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-378610-4.00245-X

DO - 10.1016/B978-0-12-378610-4.00245-X

M3 - Chapter

AN - SCOPUS:85070020731

SN - 9780123786104

SP - 513

EP - 519

BT - Encyclopedia of Sleep

PB - Elsevier Inc.

ER -